Multi-Cancer Early Detection Screening Tests: Considerations for Use of Real-World Data | March 29, 2022 Share
2021 Annual Meeting: Assessing the Use of ctDNA as an Early Endpoint in Early-Stage Disease | February 3, 2022 Share
Expedited Development of Diagnostics for Therapies Targeting Rare Biomarkers or Indications | January 26, 2022 Share
Harmonizing the Definition and Reported of Cytokine Release Syndrome (CRS) in Immuno-Oncology Clinical Trials | February 11, 2021 Share
2018 Annual Meeting: Exploring the Use of Circulating Tumor DNA as a Monitoring Tool for Drug Development | November 24, 2020 Share
2018 Annual Meeting: Exploring Whether a Synthetic Control Arm Can Be Derived from Historical Clinical Trials that Match Baseline Characteristics and Overall Survival Outcome of a Randomized Control Arm | November 24, 2020 Share
